Generic drug companies continue to face obstacles, but there is no substitute for the solutions they are implementing to meet the needs of customers and patients.
The interim staff report details how increasing vertical integration and concentration has enabled the six largest PBMs to manage nearly 95% of all prescriptions filled in the United States.